Subjects, who are planned to undergo TMS for therapeutic purpose are evaluated for history of epilepsy. Most of the RCTs that evaluated efficacy of TMS, exclude patients with history of epilepsy, considering the risks of seizure. However, evidences also support the beneficial role of TMS in epilepsy. Some interesting articles are here -
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC321221/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952325/
https://www.cochrane.org/CD011025/EPILEPSY_transcranial-magnetic-stimulation-treatment-epilepsy
Should the recommendations for use of TMS need to be broadened?
Should the future researches evaluating role of TMS in various psychiatric disorders, also include those patients with co-morbid epilepsy?